FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2147943356> ?p ?o ?g. }

• W2147943356 endingPage "41" @default.
• W2147943356 startingPage "2136" @default.
• W2147943356 abstract "Currently, no curative therapy for metastatic prostate cancer exists. Causing prostate cancer cells to express functionally active sodium iodide symporter (NIS) would enable those cells to concentrate iodide from plasma and might offer the ability to treat prostate cancer with radioiodine. Therefore, the aim of our study was to achieve tissue-specific expression of full-length human NIS (hNIS) cDNA in the androgen-sensitive human prostatic adenocarcinoma cell line LNCaP and in subcell lines C4, C4-2, and C4-2b in vitro. For this purpose, an expression vector was generated in which full-length hNIS cDNA coupled to the prostate-specific antigen (PSA) promoter has been ligated into the pEGFP-1 vector (NIS/PSA-pEGFP-1). The PSA promoter is responsible for androgen-dependent expression of PSA in benign and malignant prostate cells and was therefore used to mediate androgen-dependent prostate-specific expression of NIS. In addition, two control vectors were designed, which consist of the pEGFP-1 vector containing the PSA promoter without NIS cDNA (PSA-pEGFP-1) and NIS cDNA without the PSA promoter (NIS-pEGFP-1). Prostate cancer cells were transiently transfected with each of the above-described expression vectors, incubated with or without androgen (mibolerone) for 48 h, and monitored for iodide uptake activity. In addition, stably transfected LNCaP cell lines were established for each vector. Prostate cells transfected with NIS/PSA-pEGFP-1 showed perchlorate-sensitive, androgen-dependent iodide uptake in a range comparable to that observed in control cell lines transfected with hNIS cDNA. Perchlorate-sensitive iodide uptake was not observed in cells transfected with NIS/PSA-pEGFP-1 and treated without androgen or in cells transfected with the control vectors. In addition, prostate cancer cell lines without PSA expression (PC-3 and DU-145) did not show iodide uptake activity when transfected with NIS/PSA-pEGFP-1. Western blotting of LNCaP and C4-2b cell membranes transfected with NIS/PSA-pEGFP-1 using a monoclonal antibody that recognizes the COOH-terminus of hNIS revealed a band with a molecular weight of 90,000 that was not detected in androgen-deprived cells or in cells transfected with the control vectors, as well as a minor band at Mr 150,000 in transiently transfected LNCaP cell membranes. In conclusion, tissue-specific androgen-dependent iodide uptake activity has been induced in prostate cancer cells by PSA promoter-directed NIS expression. This study represents an initial step toward therapy of prostate cancer with radioiodine." @default.
• W2147943356 created "2016-06-24" @default.
• W2147943356 creator A5011038225 @default.
• W2147943356 creator A5014512900 @default.
• W2147943356 creator A5021821969 @default.
• W2147943356 creator A5028789695 @default.
• W2147943356 creator A5058620102 @default.
• W2147943356 creator A5063630764 @default.
• W2147943356 creator A5070640664 @default.
• W2147943356 creator A5084548713 @default.
• W2147943356 creator A5085178550 @default.
• W2147943356 date "1999-05-01" @default.
• W2147943356 modified "2023-09-28" @default.
• W2147943356 title "Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines." @default.
• W2147943356 cites W1504642746 @default.
• W2147943356 cites W1519583741 @default.
• W2147943356 cites W1973361095 @default.
• W2147943356 cites W1980226373 @default.
• W2147943356 cites W1986490016 @default.
• W2147943356 cites W1992692978 @default.
• W2147943356 cites W1993970313 @default.
• W2147943356 cites W2001471842 @default.
• W2147943356 cites W2005953810 @default.
• W2147943356 cites W2006714639 @default.
• W2147943356 cites W2023180335 @default.
• W2147943356 cites W2023396505 @default.
• W2147943356 cites W2026316938 @default.
• W2147943356 cites W2027548210 @default.
• W2147943356 cites W2034083247 @default.
• W2147943356 cites W2036493331 @default.
• W2147943356 cites W2037098580 @default.
• W2147943356 cites W2057477877 @default.
• W2147943356 cites W2065003195 @default.
• W2147943356 cites W2079033610 @default.
• W2147943356 cites W2080852072 @default.
• W2147943356 cites W2084810075 @default.
• W2147943356 cites W2110113462 @default.
• W2147943356 cites W2113008095 @default.
• W2147943356 cites W2121046418 @default.
• W2147943356 cites W2134781138 @default.
• W2147943356 cites W2151275516 @default.
• W2147943356 cites W2153057419 @default.
• W2147943356 cites W2153876645 @default.
• W2147943356 cites W2156854438 @default.
• W2147943356 cites W2162612481 @default.
• W2147943356 cites W2403017829 @default.
• W2147943356 cites W2413000262 @default.
• W2147943356 cites W2415518040 @default.
• W2147943356 cites W2416968969 @default.
• W2147943356 cites W2426719837 @default.
• W2147943356 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10232600" @default.
• W2147943356 hasPublicationYear "1999" @default.
• W2147943356 type Work @default.
• W2147943356 sameAs 2147943356 @default.
• W2147943356 citedByCount "65" @default.
• W2147943356 countsByYear W21479433562012 @default.
• W2147943356 countsByYear W21479433562014 @default.
• W2147943356 countsByYear W21479433562016 @default.
• W2147943356 countsByYear W21479433562017 @default.
• W2147943356 countsByYear W21479433562018 @default.
• W2147943356 countsByYear W21479433562020 @default.
• W2147943356 countsByYear W21479433562021 @default.
• W2147943356 countsByYear W21479433562022 @default.
• W2147943356 countsByYear W21479433562023 @default.
• W2147943356 crossrefType "journal-article" @default.
• W2147943356 hasAuthorship W2147943356A5011038225 @default.
• W2147943356 hasAuthorship W2147943356A5014512900 @default.
• W2147943356 hasAuthorship W2147943356A5021821969 @default.
• W2147943356 hasAuthorship W2147943356A5028789695 @default.
• W2147943356 hasAuthorship W2147943356A5058620102 @default.
• W2147943356 hasAuthorship W2147943356A5063630764 @default.
• W2147943356 hasAuthorship W2147943356A5070640664 @default.
• W2147943356 hasAuthorship W2147943356A5084548713 @default.
• W2147943356 hasAuthorship W2147943356A5085178550 @default.
• W2147943356 hasConcept C104317684 @default.
• W2147943356 hasConcept C120405084 @default.
• W2147943356 hasConcept C121608353 @default.
• W2147943356 hasConcept C126322002 @default.
• W2147943356 hasConcept C134018914 @default.
• W2147943356 hasConcept C149011108 @default.
• W2147943356 hasConcept C153911025 @default.
• W2147943356 hasConcept C185592680 @default.
• W2147943356 hasConcept C2776235491 @default.
• W2147943356 hasConcept C2777911890 @default.
• W2147943356 hasConcept C2779723316 @default.
• W2147943356 hasConcept C2780192828 @default.
• W2147943356 hasConcept C2780616701 @default.
• W2147943356 hasConcept C2781406297 @default.
• W2147943356 hasConcept C502942594 @default.
• W2147943356 hasConcept C54009773 @default.
• W2147943356 hasConcept C54355233 @default.
• W2147943356 hasConcept C55493867 @default.
• W2147943356 hasConcept C71315377 @default.
• W2147943356 hasConcept C71924100 @default.
• W2147943356 hasConcept C81885089 @default.
• W2147943356 hasConcept C86803240 @default.
• W2147943356 hasConceptScore W2147943356C104317684 @default.
• W2147943356 hasConceptScore W2147943356C120405084 @default.

• next